HOME › DRUGS › EMAPALUMAB-LZSG
ACTIVE SUBSTANCE / INN

EMAPALUMAB-LZSG

Brand name(s): GAMIFANT
FDA LISTED
PRESCRIPTION
BLA761107
ACTIVE SUBSTANCE
Emapalumab-Lzsg
REGULATORS
FDA
SPONSORS / MAH
NOVIMMUNE S.A.
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
GAMIFANTBLA761107NOVIMMUNE S.A.Prescription

FULL INTELLIGENCE ON EMAPALUMAB-LZSG

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →